[Federal Register Volume 68, Number 169 (Tuesday, September 2, 2003)]
[Notices]
[Page 52226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22325]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated April 29, 2003, and published in the Federal 
Register on May 29, 2003, (68 FR 32089), Organichem Corporation, 33 
Riverside Avenue, Rensselaer, New York 12144, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of the basic class of Schedule II of controlled 
substance listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dextropoxyphene (9273).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture bulk products for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Organichem Corporation to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Organichem 
Corporation to ensure that the company's registration is consistent 
with the public interest. This investigation has included inspection 
and testing of the company's physical security systems, verification of 
the company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
class of controlled substance listed is granted.

    Dated: August 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-22325 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M